Elsevier

Neuropharmacology

Volume 89, February 2015, Pages 375-381
Neuropharmacology

Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow

https://doi.org/10.1016/j.neuropharm.2014.10.016Get rights and content

Highlights

  • The 5-HT2CR is known to control dopamine neuron function.

  • The 5-HT2CR may control the effects of cocaine at postsynaptic level in the striatum.

  • Cocaine-induced striatal DA outflow is unaltered by Ro 60-0175.

  • Cocaine-induced striatal DARPP-32 phosphorylation is inhibited by Ro 60-0175.

  • Cocaine behavioral effects may involve the 5-HT2CR control of striatal DA signaling.

Abstract

The serotonin2C receptor (5-HT2CR) is known to control dopamine (DA) neuron function by modulating DA neuronal firing and DA exocytosis at terminals. Recent studies assessing the influence of 5-HT2CRs on cocaine-induced neurochemical and behavioral responses have shown that 5-HT2CRs can also modulate mesoaccumbens DA pathway activity at post-synaptic level, by controlling DA transmission in the nucleus accumbens (NAc), independently of DA release itself. A similar mechanism has been proposed to occur at the level of the nigrostriatal DA system. Here, using in vivo microdialysis in freely moving rats and molecular approaches, we assessed this hypothesis by studying the influence of the 5-HT2CR agonist Ro 60-0175 on cocaine-induced responses in the striatum. The intraperitoneal (i.p.) administration of 1 mg/kg Ro 60-0175 had no effect on the increase in striatal DA outflow induced by cocaine (15 mg/kg, i.p.). Conversely, Ro 60-0175 inhibited cocaine-induced Fos immunoreactivity and phosphorylation of the DA and c-AMP regulated phosphoprotein of Mr 32 kDa (DARPP-32) at threonine 75 residue in the striatum. Finally, the suppressant effect of Ro 60-0175 on cocaine-induced DARPP-32 phosphorylation was reversed by the selective 5-HT2CR antagonist SB 242084 (0.5 mg/kg, i.p.). In keeping with the key role of DARPP-32 in DA neurotransmission, our results demonstrate that 5-HT2CRs are capable of modulating nigrostriatal DA pathway activity at post-synaptic level, by specifically controlling DA signaling in the striatum.

Introduction

Along with its dense localization in brain dopaminergic regions, the central serotonin2C receptor (5-HT2CR) is a well-established modulator of dopamine (DA) systems (Alex and Pehek, 2007, Berg et al., 2008), and is currently considered as a promising pharmacological target for improved treatments of DA-related disorders, such as Parkinson's disease, depression, schizophrenia and drug addiction (Millan, 2005, Di Giovanni et al., 2006, Müller and Huston, 2006, Filip et al., 2012, Meltzer et al., 2012, Cunningham et al., 2013, Higgins et al., 2013).

Compelling evidence indicates that 5-HT2CRs afford an overall inhibitory control on the mesocorticolimbic and nigrostriatal DA pathways (Berg et al., 2008, Aloyo et al., 2009). In particular, electrophysiological and neurochemical studies have shown that 5-HT2CRs modulate DA neuronal function by controlling both DA neuronal firing and DA exocytosis at terminals (Porras et al., 2002, Navailles et al., 2004, Berg et al., 2008). Studies assessing the role of 5-HT2CRs in the neurochemical and behavioral effects of cocaine have shown that the 5-HT2CR agonist Ro 60-0175 has no effect on striatal and accumbal DA release in halothane-anaesthetized rats (Navailles et al., 2004), but inhibits cocaine-induced DA-dependent behaviors, such as hyperlocomotive, discriminative stimulus and reinforcing properties (Filip et al., 2012, Devroye et al., 2013). These findings led to the proposal that 5-HT2CRs could also regulate the activity of subcortical DA pathways at postsynaptic level, by controlling DA transmission in the nucleus accumbens (NAc) and the striatum independently of DA release (Navailles et al., 2004). We have recently confirmed this hypothesis at the level of the mesoaccumbens DA pathway, by showing that the peripheral administration of Ro 60-0175 is able to inhibit cocaine-induced phosphorylation of the DA and c-AMP regulated phosphoprotein Mr 32 kDa (DARPP-32) in the NAc (Cathala et al., 2014). Specifically, DARPP-32, in agreement with its location in dopaminoceptive neurons and its key role in DA signaling, provides a useful tool for evaluating DA neurotransmission (Nishi et al., 2000).

Thus, given the importance of the nigrostriatal DA system in the effects of cocaine (Koob and Volkow, 2010, Wise, 2009; Pierce and Vanderschuren, 2010), the present study was aimed at investigating whether, as for the mesoaccumbens DA pathway (Cathala et al., 2014), 5-HT2CR stimulation modulates nigrostriatal DA pathway activity at postsynaptic level, by controlling DA transmission in the striatum independently of DA release itself.

To this purpose, we assessed the ability of Ro 60-0175 to modulate cocaine-induced changes of DA activity at both pre- and post-synaptic levels. Specifically, using intracerebral microdialysis in freely moving rats, we first studied the effect of Ro 60-0175 on cocaine-induced striatal DA outflow, as an index of pre-synaptic DA neuron activity (Panin et al., 2012). Second, to evaluate possible changes of post-synaptic neuronal activity, we assessed the effect of Ro 60-0175 on cocaine-induced changes of Fos immunoreactivity, and phosphorylation states at threonine 34 and 75 residues of DARPP-32. Finally, the specific involvement of 5-HT2CRs in the effect of Ro 60-0175 on cocaine-induced DARPP-32 phosphorylation was studied in animals pretreated with the selective 5-HT2CR antagonist SB 242084 (Kennett et al., 1997).

Section snippets

Animals

Male Sprague Dawley rats (IFFA CREDO, Lyon, France) weighing 320–350 g were used. Animals, housed in individual plastic cages, were kept at constant room temperature (21 ± 2 °C) and relative humidity (60%) with a 12 h light/dark cycle (dark from 20:00 h) and had free access to water and food. Animals were acclimated to the housing conditions for at least one week prior to the start of the experiments. All experiments were conducted during the light phase of the light–dark cycle. Animal use

Effect of the 5-HT2CR agonist Ro 60-0175 on cocaine-induced increase in striatal DA outflow

Fig. 1 illustrates the effect of Ro 60-0175 on cocaine-induced increase in DA outflow in the striatum. Statistical analysis revealed a significant main effect of treatment (Fcoc (1,19) = 57.85, p < 0.001) and a significant treatment by time interaction (Fcoc × time (9,171) = 28.79, p < 0.001). As expected (Navailles et al., 2004), cocaine elicited an overall significant increase in DA outflow, which reached its significance 30 min after injection and remained significant during the entire

Discussion

The present study shows that agonist-induced stimulation of 5-HT2CRs has no effect on cocaine-evoked striatal DA outflow, but reduces cocaine-induced Fos expression and DARPP-32 phosphorylation in the striatum. In keeping with the key role of DARPP-32 in DA signaling (Svenningsson et al., 2002), these findings provide the first evidence that 5-HT2CRs are capable of modulating nigrostriatal DA pathway activity at post-synaptic level by controlling DA transmission in the striatum, thereby

Acknowledgments

This work was supported by grants from the Institut National de la Recherche et de la Santé (INSERM), Bordeaux University and Labex Brain ANR-10-LABX-43. The authors wish to thank C. Dupuy, V. Roullot-Lacarrière and A. Le Roux for technical assistance.

References (58)

  • M. Maitre et al.

    Western blot detection of brain phosphoproteins after performing Laser Microdissection and Pressure Catapulting (LMPC)

    J. Neurosci. Methods

    (2011)
  • M.J. Millan

    Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies

    Therapie

    (2005)
  • C.P. Müller et al.

    Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine

    Trends Pharmacol. Sci.

    (2006)
  • F. Panin et al.

    Coupled intracerebral microdialysis and electrophysiology for the assessment of dopamine neuron function in vivo

    J. Pharmacol. Toxicol. Methods

    (2012)
  • R.C. Pierce et al.

    Kicking the habit: the neural basis of ingrained behaviors in cocaine addiction

    Neurosci. Biobehav. Rev.

    (2010)
  • G. Porras et al.

    5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum

    Neuropsychopharmacology

    (2002)
  • W.L. Sun et al.

    Effects of acute cocaine on ERK and DARPP-32 phosphorylation pathways in the caudate-putamen of Fischer rats

    Brain Res.

    (2007)
  • T.S. Tang et al.

    Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons

    J. Biol. Chem.

    (2004)
  • R.A. Wise

    Roles for nigrostriatal-not just mesocorticolimbic-dopamine in reward and addiction

    Trends Neurosci.

    (2009)
  • C.M. Atkins et al.

    Bidirectional regulation of cytoplasmic polyadenylation element-binding protein phosphorylation by Ca2+/calmodulin-dependent protein kinase II and protein phosphatase 1 during hippocampal long-term potentiation

    J. Neurosci.

    (2005)
  • A.L. Auclair et al.

    The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity

    J. Neurochem.

    (2010)
  • M. Barrot et al.

    The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent

    Eur. J. Neurosci.

    (2000)
  • M. Barrot et al.

    Functional heterogeneity in dopamine release and in the expression of Fos-like proteins within the rat striatal complex

    Eur. J. Neurosci.

    (1999)
  • H.S. Bateup et al.

    Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs

    Nat. Neurosci.

    (2008)
  • J.M. Beaulieu et al.

    Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

    Proc. Natl. Acad. Sci. U. S. A.

    (2004)
  • J.A. Beeler et al.

    Loss of cocaine locomotor response in Pitx3-deficient mice lacking a nigrostriatal pathway

    Neuropsychopharmacology

    (2009)
  • A. Belkhiri et al.

    Darpp-32: a novel antiapoptotic gene in upper gastrointestinal carcinomas

    Cancer Res.

    (2005)
  • S. Burbassi et al.

    Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats

    Psychopharmacology (Berl)

    (2008)
  • A. Cathala et al.

    Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine

    Addict. Biol.

    (2014)
  • Cited by (14)

    • Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence

      2021, Progress in Brain Research
      Citation Excerpt :

      The increase in DA extracellular levels induced by amphetamine (impulse-independent) is not modified by 5-HT2C ligands. The increase in DA extracellular levels induced by cocaine is not modified by 5-HT2C agonists (Cathala et al., 2015; Devroye et al., 2015; Navailles et al., 2004; Willins and Meltzer, 1998) and slightly potentiated by the 5-HT2B/2C inverse agonist SB206553 or the 5-HT2C antagonist SB242084 (Navailles et al., 2004). 5-HT2C receptors have been proposed as a valuable target in numerous CNS disorders as we extensively reviewed recently (Di Giovanni and De Deurwaerdere, 2016) and they are still the object of numerous investigations in 2021 (De Deurwaerdère et al., 2020b; Di Giovanni and De Deurwaerdère, 2020).

    • Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats

      2020, Neuropharmacology
      Citation Excerpt :

      On the other hand, it should be kept in mind that the inhibitory action of 5-HT2CR agonists on behavior is not necessarily associated with a decrease in DA release in the NAc (see (De Deurwaerdere and Di Giovanni, 2017). The behavioral effects of cocaine, for instance, are reduced by 5-HT2CR agonists independently from an action on DA release (Cathala et al., 2015; Devroye et al., 2015). Moreover, a lack of parallelism has been shown between the electrophysiological and microdialysis data (De Deurwaerdere and Di Giovanni, 2017).

    • The central serotonin<inf>2B</inf> receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research

      2018, Pharmacology and Therapeutics
      Citation Excerpt :

      Importantly, similar effects have already been described in the literature with the 5-HT2CR, which is currently considered as a promising pharmacological target for treating drug addiction (Filip, Spampinato, McCreary, & Przegaliński, 2012; Higgins & Fletcher, 2015). Indeed, the ability of 5-HT2CRs to regulate cocaine-induced phosphorylation of the DA and c-AMP-regulated phosphoproteins Mr 32 kDa (DARPP-32, a marker of DA neurotransmission; Nishi et al., 2000) in the NAc and the striatum, independently of subcortical DA outflow, could account for the suppressive effect of the systemic administration of 5-HT2CR agonists on cocaine-induced hyperlocomotion (Cathala et al., 2015; Devroye, Cathala, Maitre et al., 2015). Furthermore, these changes of NAc and striatal DA transmission could result from an action at the level of the mPFC, as cocaine-induced hyperactivity is also suppressed following intra-mPFC administration of 5-HT2CR agonists (Filip & Cunningham, 2003).

    View all citing articles on Scopus
    View full text